These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15160994)

  • 21. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
    Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
    Bracey TS; Williams AC; Paraskeva C
    Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cell cycle in mediating sensitivity to radiotherapy.
    Pawlik TM; Keyomarsi K
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.
    Badie C; Bourhis J; Sobczak-Thépot J; Haddada H; Chiron M; Janicot M; Janot F; Tursz T; Vassal G
    Br J Cancer; 2000 Feb; 82(3):642-50. PubMed ID: 10682678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
    Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity.
    Fernet M; Mégnin-Chanet F; Hall J; Favaudon V
    DNA Repair (Amst); 2010 Jan; 9(1):48-57. PubMed ID: 19926348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells.
    Namba H; Hara T; Tukazaki T; Migita K; Ishikawa N; Ito K; Nagataki S; Yamashita S
    Cancer Res; 1995 May; 55(10):2075-80. PubMed ID: 7743505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cycle effects of topotecan alone and in combination with irradiation.
    Ohneseit PA; Prager D; Kehlbach R; Rodemann HP
    Radiother Oncol; 2005 May; 75(2):237-45. PubMed ID: 15890420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
    Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
    Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia.
    Didier C; Cavelier C; Quaranta M; Demur C; Ducommun B
    Eur J Pharmacol; 2008 Sep; 591(1-3):102-5. PubMed ID: 18616938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.
    Xu B; O'Donnell AH; Kim ST; Kastan MB
    Cancer Res; 2002 Aug; 62(16):4588-91. PubMed ID: 12183412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
    Ree AH; Bratland A; Nome RV; Stokke T; Fodstad O; Andersson Y
    Radiother Oncol; 2004 Sep; 72(3):305-10. PubMed ID: 15450729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polo-like kinase, a novel marker for cellular proliferation.
    Yuan J; Hörlin A; Hock B; Stutte HJ; Rübsamen-Waigmann H; Strebhardt K
    Am J Pathol; 1997 Apr; 150(4):1165-72. PubMed ID: 9094972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death.
    Nome RV; Bratland A; Harman G; Fodstad O; Andersson Y; Ree AH
    Mol Cancer Ther; 2005 Aug; 4(8):1231-8. PubMed ID: 16093439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues.
    Winkles JA; Alberts GF
    Oncogene; 2005 Jan; 24(2):260-6. PubMed ID: 15640841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocytes.
    Georgescu SP; Komuro I; Hiroi Y; Mizuno T; Kudoh S; Yamazaki T; Yazaki Y
    J Mol Cell Cardiol; 1997 Mar; 29(3):929-37. PubMed ID: 9152854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of phospholipase Cgamma on Polo-like kinase 1 expression in human glioma cells.
    Dietzmann K; Kirches E; Mawrin C
    J Cancer Res Clin Oncol; 2002 May; 128(5):265-70. PubMed ID: 12029442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines.
    Simizu S; Osada H
    Nat Cell Biol; 2000 Nov; 2(11):852-4. PubMed ID: 11056542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.
    Flatmark K; Nome RV; Folkvord S; Bratland A; Rasmussen H; Ellefsen MS; Fodstad Ø; Ree AH
    Radiat Oncol; 2006 Aug; 1():25. PubMed ID: 16887021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.